Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Gorman Kevin Charles sold 245,088 Neurocrine Biosciences, Inc. shares (Form 4)
Traded May 19, 2026 · Filed May 21, 2026
On May 19, 2026, Gorman Kevin Charles (Director) sold 245,088 Neurocrine Biosciences, Inc. shares at US$154.33 for US$37.8M under a trading plan, leaving 511,293 shares. Filed May 21, 2026 (Form 4).
- Sold
- 245,088 shares
- Price
- US$154.33
- Value
- US$37.8M
- Holding after
- 511,293 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | Option exercise | 205,088 | US$43.24 | 756,381 | Direct |
| May 19, 2026 | Common Stock | Sale | 245,088 | US$154.33 | 511,293 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Gorman Kevin Charles
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Gorman Kevin Charles · Sep 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026